Sodium Iodide I123

Sodium Iodide I123 is a radioactive iodine tracer used in diagnostic imaging for thyroid conditions. This radiopharmaceutical helps evaluate thyroid function and detect abnormalities. It is administered intravenously under medical supervision. Commonly used in nuclear medicine scans.

Sodium Iodide I123 is primarily used for diagnostic imaging of the thyroid gland. It helps assess thyroid function and identify conditions such as hyperthyroidism or thyroid nodules. This radiopharmaceutical is also used in thyroid cancer follow-up imaging. It provides detailed visualization of thyroid tissue for accurate diagnosis.

After administration, Sodium Iodide I123 is absorbed by the thyroid gland, emitting gamma radiation detectable by imaging equipment. This allows for clear visualization of thyroid structure and function. Patients may experience mild discomfort at the injection site. The effects are temporary and resolve as the tracer clears from the body.

Sodium Iodide I123 should only be handled and administered by trained medical professionals. Pregnant or breastfeeding individuals should avoid exposure due to potential risks to the fetus or infant. Patients should inform their healthcare provider about any allergies or recent iodine exposure. Proper shielding and safety protocols are required during handling.

Certain medications, such as thyroid hormones or antithyroid drugs, may interfere with the uptake of Sodium Iodide I123. Patients should disclose all current medications to their healthcare provider. Contrast agents used in imaging may also affect results. Alcohol and specific dietary supplements may need to be avoided before the procedure.